The polyphenolic 1,2,3,4,6-penta- O-galloyl-beta-d-glucose from several medicinal herbs triggers apoptosis and has, thus, been proposed for treatment of malignancy. The substance is at least partially effective through caspase activation. In analogy to apoptosis of nucleated cells, erythrocytes may enter suicidal death or eryptosis, which is characterized by cell shrinkage and by phosphatidylserine translocation to the erythrocyte surface. Eryptosis is triggered by increase of cytosolic Ca 2+-activity ([Ca 2+]i). The sensitivity to [Ca 2+]i is enhanced by ceramide. The present study explored whether penta- O-galloyl-β-d-glucose stimulates eryptosis. Cell volume was estimated from forward scatter, phosphatidylserine exposure from annexin V binding, hemolysis from hemoglobin-release, [Ca 2+]i from Fluo3-fluorescence and ceramide abundance from fluorescent antibodies. A 48-h exposure of human erythrocytes to penta- O-galloyl-β-d-glucose significantly decreased forward scatter (50 μM) and significantly increased annexin V binding (10 μM). Up to 50 μM penta- O-galloyl-β-d-glucose did not significantly modify [Ca 2+]i. However, the effect of penta- O-galloyl-β-d-glucose (25 μM) induced annexin V binding was slightly, but significantly, blunted by removal of extracellular Ca 2+, pointing to sensitization of erythrocytes to the scrambling effect of Ca 2+. Penta- O-galloyl-β-d-glucose (25 μM) further increased ceramide formation. In conclusion, penta- O-galloyl-β-d-glucose stimulates suicidal erythrocyte death or eryptosis, an effect partially due to stimulation of ceramide formation with subsequent sensitization of erythrocytes to Ca 2+.
References
[1]
Zhang, J.; Li, L.; Kim, S.H.; Hagerman, A.E.; Lu, J. Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose. Pharm. Res. 2009, 26, 2066–2080, doi:10.1007/s11095-009-9932-0.
[2]
Hu, H.; Zhang, J.; Lee, H.J.; Kim, S.H.; Lu, J. Penta-O-galloyl-beta-d-glucose induces s- and g(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin d1. Carcinogenesis 2009, 30, 818–823, doi:10.1093/carcin/bgp059.
[3]
Chai, Y.; Lee, H.J.; Shaik, A.A.; Nkhata, K.; Xing, C.; Zhang, J.; Jeong, S.J.; Kim, S.H.; Lu, J. Penta-O-galloyl-beta-d-glucose induces g1 arrest and DNA replicative s-phase arrest independently of cyclin-dependent kinase inhibitor 1a, cyclin-dependent kinase inhibitor 1b and p53 in human breast cancer cells and is orally active against triple negative xenograft growth. Breast Cancer Res. 2010, 12, R67, doi:10.1186/bcr2634.
[4]
Oh, G.S.; Pae, H.O.; Oh, H.; Hong, S.G.; Kim, I.K.; Chai, K.Y.; Yun, Y.G.; Kwon, T.O.; Chung, H.T. In vitro anti-proliferative effect of 1,2,3,4,6-penta-O-galloyl-beta-d-glucose on human hepatocellular carcinoma cell line, sk-hep-1 cells. Cancer Lett. 2001, 174, 17–24, doi:10.1016/S0304-3835(01)00680-2.
[5]
Kiss, A.K.; Filipek, A.; Zyzynska-Granica, B.; Naruszewicz, M. Effects of penta-O-galloyl-beta-d-glucose on human neutrophil function: Significant down-regulation of l-selectin expression. Phytother. Res. 2013, 27, 986–992, doi:10.1002/ptr.4822.
[6]
Lee, H.J.; Jeong, S.J.; Lee, H.J.; Lee, E.O.; Bae, H.; Lieske, J.C.; Kim, S.H. 1,2,3,4,6-penta-O-galloyl-beta-d-glucose reduces renal crystallization and oxidative stress in a hyperoxaluric rat model. Kidney Int. 2011, 79, 538–545, doi:10.1038/ki.2010.458.
[7]
Bing, S.J.; Kim, M.J.; Park, E.; Ahn, G.; Kim, D.S.; Ko, R.K.; Lee, N.H.; Shin, T.; Park, J.W.; Jee, Y. 1,2,3,4,6-Penta-O-galloyl-beta-d-glucose protects splenocytes against radiation-induced apoptosis in murine splenocytes. Biol. Pharm. Bull. 2010, 33, 1122–1127, doi:10.1248/bpb.33.1122.
[8]
Huang, C.; Lee, S.Y.; Lin, C.L.; Tu, T.H.; Chen, L.H.; Chen, Y.J.; Huang, H.C. Co-treatment with quercetin and 1,2,3,4,6-penta-O-galloyl-beta-d-glucose causes cell cycle arrest and apoptosis in human breast cancer mda-mb-231 and au565 cells. J. Agric. Food Chem. 2013, 61, 6430–6445, doi:10.1021/jf305253m.
[9]
Kwon, T.R.; Jeong, S.J.; Lee, H.J.; Lee, H.J.; Sohn, E.J.; Jung, J.H.; Kim, J.H.; Jung, D.B.; Lu, J.; Kim, S.H. Reactive oxygen species-mediated activation of jnk and down-regulation of daxx are critically involved in penta-O-galloyl-beta-d-glucose-induced apoptosis in chronic myeloid leukemia k562 cells. Biochem. Biophys. Res. Commun. 2012, 424, 530–537, doi:10.1016/j.bbrc.2012.06.150.
[10]
Ryu, H.G.; Jeong, S.J.; Kwon, H.Y.; Lee, H.J.; Lee, E.O.; Lee, M.H.; Choi, S.H.; Ahn, K.S.; Kim, S.H. Penta-O-galloyl-beta-d-glucose attenuates cisplatin-induced nephrotoxicity via reactive oxygen species reduction in renal epithelial cells and enhances antitumor activity in caki-2 renal cancer cells. Toxicol. in Vitro 2012, 26, 206–214, doi:10.1016/j.tiv.2011.11.012.
[11]
Lee, H.J.; Seo, N.J.; Jeong, S.J.; Park, Y.; Jung, D.B.; Koh, W.; Lee, H.J.; Lee, E.O.; Ahn, K.S.; Ahn, K.S.; et al. Oral administration of penta-O-galloyl-beta-d-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with jak1-stat3 inhibition. Carcinogenesis 2011, 32, 804–811, doi:10.1093/carcin/bgr015.
[12]
Huh, J.E.; Lee, E.O.; Kim, M.S.; Kang, K.S.; Kim, C.H.; Cha, B.C.; Surh, Y.J.; Kim, S.H. Penta-O-galloyl-beta-d-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: Roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Carcinogenesis 2005, 26, 1436–1445, doi:10.1093/carcin/bgi097.
[13]
Pan, M.H.; Lin, J.H.; Lin-Shiau, S.Y.; Lin, J.K. Induction of apoptosis by penta-O-galloyl-beta-d-glucose through activation of caspase-3 in human leukemia hl-60 cells. Eur. J. Pharmacol. 1999, 381, 171–183, doi:10.1016/S0014-2999(99)00549-X.
[14]
Park, E.J.; Zhao, Y.Z.; An, R.B.; Kim, Y.C.; Sohn, D.H. 1,2,3,4,6-Penta-O-galloyl-beta-d-glucose from galla rhois protects primary rat hepatocytes from necrosis and apoptosis. Planta Med. 2008, 74, 1380–1383, doi:10.1055/s-2008-1081300.
[15]
Lang, E.; Qadri, S.M.; Lang, F. Killing me softly—Suicidal erythrocyte death. Int. J.Biochem. Cell.Biol. 2012, 44, 1236–1243, doi:10.1016/j.biocel.2012.04.019.
[16]
Foller, M.; Sopjani, M.; Koka, S.; Gu, S.; Mahmud, H.; Wang, K.; Floride, E.; Schleicher, E.; Schulz, E.; Munzel, T.; et al. Regulation of erythrocyte survival by amp-activated protein kinase. FASEB J. 2009, 23, 1072–1080, doi:10.1096/fj.08-121772.
[17]
Bookchin, R.M.; Ortiz, O.E.; Lew, V.L. Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog. Clin. Biol. Res. 1987, 240, 193–200.
[18]
Brugnara, C.; De Franceschi, L.; Alper, S.L. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J. Clin. Invest. 1993, 92, 520–526, doi:10.1172/JCI116597.
[19]
Lang, P.A.; Kaiser, S.; Myssina, S.; Wieder, T.; Lang, F.; Huber, S.M. Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am. J. Physiol. Cell. Physiol. 2003, 285, C1553–C1560, doi:10.1152/ajpcell.00186.2003.
[20]
Berg, C.P.; Engels, I.H.; Rothbart, A.; Lauber, K.; Renz, A.; Schlosser, S.F.; Schulze-Osthoff, K.; Wesselborg, S. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell. Death Differ. 2001, 8, 1197–1206, doi:10.1038/sj.cdd.4400905.
[21]
Lau, I.P.; Chen, H.; Wang, J.; Ong, H.C.; Leung, K.C.; Ho, H.P.; Kong, S.K. In vitro effect of ctab- and peg-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2011, doi:10.3109/17435390.2011.625132.
[22]
Maellaro, E.; Leoncini, S.; Moretti, D.; Del Bello, B.; Tanganelli, I.; De Felice, C.; Ciccoli, L. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol. 2011, doi:10.1007/s00592-011-0274-0.
[23]
Foller, M.; Feil, S.; Ghoreschi, K.; Koka, S.; Gerling, A.; Thunemann, M.; Hofmann, F.; Schuler, B.; Vogel, J.; Pichler, B.; et al. Anemia and splenomegaly in cgki-deficient mice. Proc. Natl. Acad. Sci. USA 2008, 105, 6771–6776, doi:10.1073/pnas.0708940105.
[24]
Bhavsar, S.K.; Gu, S.; Bobbala, D.; Lang, F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell. Physiol. Biochem. 2011, 27, 547–556, doi:10.1159/000329956.
[25]
Kucherenko, Y.V.; Huber, S.M.; Nielsen, S.; Lang, F. Decreased redox-sensitive erythrocyte cation channel activity in aquaporin 9-deficient mice. J. Membr. Biol. 2012, 245, 797–805, doi:10.1007/s00232-012-9482-y.
[26]
Zelenak, C.; Eberhard, M.; Jilani, K.; Qadri, S.M.; Macek, B.; Lang, F. Protein kinase ck1alpha regulates erythrocyte survival. Cell. Physiol. Biochem. 2012, 29, 171–180, doi:10.1159/000337598.
[27]
Gatidis, S.; Zelenak, C.; Fajol, A.; Lang, E.; Jilani, K.; Michael, D.; Qadri, S.M.; Lang, F. P38 mapk activation and function following osmotic shock of erythrocytes. Cell. Physiol. Biochem. 2011, 28, 1279–1286, doi:10.1159/000335859.
[28]
Lupescu, A.; Shaik, N.; Jilani, K.; Zelenak, C.; Lang, E.; Pasham, V.; Zbidah, M.; Plate, A.; Bitzer, M.; Foller, M.; et al. Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: An in vivo and in vitro study. Cell. Physiol. Biochem. 2012, 30, 876–888, doi:10.1159/000341465.
Morad, S.A.; Cabot, M.C. Ceramide-orchestrated signalling in cancer cells. Nat. Rev. Cancer 2013, 13, 51–65, doi:10.1038/nrc3398.
[31]
Borst, O.; Abed, M.; Alesutan, I.; Towhid, S.T.; Qadri, S.M.; Foller, M.; Gawaz, M.; Lang, F. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via cxcl16/sr-psox. Am. J. Physiol. Cell. Physiol. 2012, 302, C644–C651, doi:10.1152/ajpcell.00340.2011.
[32]
Andrews, D.A.; Low, P.S. Role of red blood cells in thrombosis. Curr. Opin. Hematol. 1999, 6, 76–82, doi:10.1097/00062752-199903000-00004.
[33]
Closse, C.; Dachary-Prigent, J.; Boisseau, M.R. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br. J. Haematol. 1999, 107, 300–302, doi:10.1046/j.1365-2141.1999.01718.x.
Pandolfi, A.; Di Pietro, N.; Sirolli, V.; Giardinelli, A.; Di Silvestre, S.; Amoroso, L.; Di Tomo, P.; Capani, F.; Consoli, A.; Bonomini, M. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J. Cell. Physiol. 2007, 213, 699–709, doi:10.1002/jcp.21138.
Chung, S.M.; Bae, O.N.; Lim, K.M.; Noh, J.Y.; Lee, M.Y.; Jung, Y.S.; Chung, J.H. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 414–421.
[38]
Zwaal, R.F.; Comfurius, P.; Bevers, E.M. Surface exposure of phosphatidylserine in pathological cells. Cell. Mol. Life Sci. 2005, 62, 971–988, doi:10.1007/s00018-005-4527-3.
[39]
Braun, M.; Foller, M.; Gulbins, E.; Lang, F. Eryptosis triggered by bismuth. Biometals 2009, 22, 453–460, doi:10.1007/s10534-008-9180-5.
[40]
Felder, K.M.; Hoelzle, K.; Ritzmann, M.; Kilchling, T.; Schiele, D.; Heinritzi, K.; Groebel, K.; Hoelzle, L.E. Hemotrophic mycoplasmas induce programmed cell death in red blood cells. Cell. Physiol. Biochem. 2011, 27, 557–564, doi:10.1159/000329957.
[41]
Ghashghaeinia, M.; Toulany, M.; Saki, M.; Bobbala, D.; Fehrenbacher, B.; Rupec, R.; Rodemann, H.P.; Ghoreschi, K.; Rocken, M.; Schaller, M.; et al. The nfkb pathway inhibitors bay 11-7082 and parthenolide induce programmed cell death in anucleated erythrocytes. Cell. Physiol. Biochem. 2011, 27, 45–54, doi:10.1159/000325204.
[42]
Lang, E.; Jilani, K.; Zelenak, C.; Pasham, V.; Bobbala, D.; Qadri, S.M.; Lang, F. Stimulation of suicidal erythrocyte death by benzethonium. Cell. Physiol. Biochem. 2011, 28, 347–354, doi:10.1159/000331751.
[43]
Nguyen, D.B.; Wagner-Britz, L.; Maia, S.; Steffen, P.; Wagner, C.; Kaestner, L.; Bernhardt, I. Regulation of phosphatidylserine exposure in red blood cells. Cell. Physiol. Biochem. 2011, 28, 847–856, doi:10.1159/000335798.
Zbidah, M.; Lupescu, A.; Shaik, N.; Lang, F. Gossypol-induced suicidal erythrocyte death. Toxicology 2012, 302, 101–105, doi:10.1016/j.tox.2012.09.010.
[48]
Abed, M.; Towhid, S.T.; Shaik, N.; Lang, F. Stimulation of suicidal death of erythrocytes by rifampicin. Toxicology 2012, 302, 123–128, doi:10.1016/j.tox.2012.10.006.
[49]
Lupescu, A.; Jilani, K.; Zbidah, M.; Lang, F. Induction of apoptotic erythrocyte death by rotenone. Toxicology 2012, 300, 132–137, doi:10.1016/j.tox.2012.06.007.
[50]
Lang, E.; Modicano, P.; Arnold, M.; Bissinger, R.; Faggio, C.; Abed, M.; Lang, F. Effect of thioridazine on erythrocytes. Toxins 2013, 5, 1918–1931, doi:10.3390/toxins5101918.
[51]
Calderon-Salinas, J.V.; Munoz-Reyes, E.G.; Guerrero-Romero, J.F.; Rodriguez-Moran, M.; Bracho-Riquelme, R.L.; Carrera-Gracia, M.A.; Quintanar-Escorza, M.A. Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Mol. Cell. Biochem. 2011, 357, 171–179, doi:10.1007/s11010-011-0887-1.
[52]
Myssina, S.; Huber, S.M.; Birka, C.; Lang, P.A.; Lang, K.S.; Friedrich, B.; Risler, T.; Wieder, T.; Lang, F. Inhibition of erythrocyte cation channels by erythropoietin. J. Am. Soc. Nephrol. 2003, 14, 2750–2757, doi:10.1097/01.ASN.0000093253.42641.C1.
[53]
Lang, P.A.; Beringer, O.; Nicolay, J.P.; Amon, O.; Kempe, D.S.; Hermle, T.; Attanasio, P.; Akel, A.; Schafer, R.; Friedrich, B.; et al. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J. Mol. Med. 2006, 84, 378–388, doi:10.1007/s00109-006-0058-0.
[54]
Kempe, D.S.; Akel, A.; Lang, P.A.; Hermle, T.; Biswas, R.; Muresanu, J.; Friedrich, B.; Dreischer, P.; Wolz, C.; Schumacher, U.; et al. Suicidal erythrocyte death in sepsis. J. Mol. Med. 2007, 85, 273–281, doi:10.1007/s00109-006-0123-8.
Foller, M.; Bobbala, D.; Koka, S.; Huber, S.M.; Gulbins, E.; Lang, F. Suicide for survival—Death of infected erythrocytes as a host mechanism to survive malaria. Cell. Physiol. Biochem. 2009, 24, 133–140, doi:10.1159/000233238.
[57]
Lang, P.A.; Schenck, M.; Nicolay, J.P.; Becker, J.U.; Kempe, D.S.; Lupescu, A.; Koka, S.; Eisele, K.; Klarl, B.A.; Rubben, H.; et al. Liver cell death and anemia in wilson disease involve acid sphingomyelinase and ceramide. Nat. Med. 2007, 13, 164–170, doi:10.1038/nm1539.
[58]
Kempe, D.S.; Lang, P.A.; Duranton, C.; Akel, A.; Lang, K.S.; Huber, S.M.; Wieder, T.; Lang, F. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J. 2006, 20, 368–370.
[59]
Birka, C.; Lang, P.A.; Kempe, D.S.; Hoefling, L.; Tanneur, V.; Duranton, C.; Nammi, S.; Henke, G.; Myssina, S.; Krikov, M.; et al. Enhanced susceptibility to erythrocyte “apoptosis” following phosphate depletion. Pflugers. Arch. 2004, 448, 471–477.
[60]
Zappulla, D. Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: Adaptations to CO2 increases? J. Cardiometab. Syndr. 2008, 3, 30–34, doi:10.1111/j.1559-4572.2008.07263.x.
